Mammaplasty
43
7
9
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.7%
2 terminated out of 43 trials
91.7%
+5.1% vs benchmark
12%
5 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 22 completed trials
Clinical Trials (43)
The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population
The Quest for Opioid-Free Analgesia in Reduction Mammoplasty: A Comparative Analysis of PECS, SAP Blocks, and Tumescent Infiltration
SPSIP Block for Pain Control After Breast Reduction Surgery
Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty
Physiotherapy After Breast Reduction Surgery
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
Custom Breast Implants With 3D Imaging
Clinical Study on Tissue Preservation in Breast Augmentation and Reconstruction
Safety and Performance of Motiva® Sizers
NovoX®Cup as Primary Dressing After Breast Reduction
Electrical Stimulation for Improving Postoperative Breast Sensation
Motiva Flora® Aesthetic Breast Recon® Clinical Study
NPWT Reduction Mammaplasty
The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery
Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.
Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty
Comparison of ESP and SPSIP Blocks in Breast Surgery
Diced Cartilage in Breast Reconstruction
ARTISS a Single-centre Randomised Control Study